| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 0 | 0 | 0 | 643 | 461 | 750 | 2.555 | 955 |
| Total Income - EUR | 0 | 0 | 0 | 0 | 0 | 643 | 461 | 750 | 2.555 | 3.769 |
| Total Expenses - EUR | 394 | 630 | 480 | 641 | 820 | 3.689 | 2.341 | 3.127 | 2.725 | 2.968 |
| Gross Profit/Loss - EUR | -394 | -630 | -480 | -641 | -820 | -3.046 | -1.880 | -2.377 | -170 | 802 |
| Net Profit/Loss - EUR | -394 | -630 | -480 | -641 | -820 | -3.065 | -1.893 | -2.399 | -170 | 676 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Davamed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 6.407 | 12.976 | 10.984 | 8.924 | 6.922 |
| Current Assets | 12.023 | 11.026 | 10.097 | 9.183 | 8.185 | 111 | 151 | 349 | 370 | 201 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 108 | 0 |
| Cash | 12.023 | 11.026 | 10.097 | 9.183 | 8.185 | 111 | 151 | 349 | 263 | 201 |
| Shareholders Funds | 11.413 | 10.667 | 10.007 | 9.183 | 8.185 | 4.965 | 2.961 | 571 | 400 | 1.074 |
| Social Capital | 67 | 67 | 66 | 64 | 63 | 62 | 61 | 61 | 61 | 60 |
| Debts | 610 | 359 | 90 | 0 | 0 | 1.553 | 10.166 | 10.761 | 8.895 | 6.049 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8690 - 8690" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Davamed Srl